Cardiac complications of halofantrine: a prospective study of 20 patients
Simon Szwandt
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995
View PDFchevron_right
Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model
Christopher Porter, Michelle McIntosh
Journal of Pharmacy and Pharmacology, 2004
View PDFchevron_right
Effect of a single oral dose of FansidarTM on the pharmacokinetics of halofantrine in healthy volunteers: a preliminary report
Francis Hombhanje
British Journal of Clinical Pharmacology, 2001
View PDFchevron_right
Effect of a single oral dose of Fansidar on the pharmacokinetics of halofantrine in healthy volunteers: a preliminary report
Francis Hombhanje
British journal of clinical pharmacology, 2000
View PDFchevron_right
Effects of tetracycline on the pharmacokinetics of halofantrine in healthy volunteers
Peter U Bassi
British Journal of Clinical Pharmacology, 2004
View PDFchevron_right
Halofantrine Safety, Tolerance and Metabolism Studies
Jean Barbey
1997
View PDFchevron_right
Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers
Chinedum P E A C E Babalola
Journal of Clinical Pharmacy and Therapeutics, 2009
View PDFchevron_right
Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base
Martin Danis
Malaria journal, 2009
View PDFchevron_right
Examination of Baseline Risk Factors for QTc Interval Prolongation in Patients Prescribed Intravenous Haloperidol
Jane Gagliardi
Drug Safety, 2012
View PDFchevron_right
Pharmacokinetic changes of halofantrine in experimentally-induced diabetes mellitus following oral drug administration
Michael O Daniyan
View PDFchevron_right
Patterns of Change in the Electrocardiogram after Halofantrine Treatment of Acute Uncomplicated Falciparum Malaria in Children
Ahmed A Adedeji
Clinical Drug Investigation, 2000
View PDFchevron_right
Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state
Christopher Porter
Journal of Pharmaceutical Sciences, 1998
View PDFchevron_right
Effects of Prior Administration of Amodiaquine on the Disposition of Halofantrine in Healthy Volunteers
Michael O Daniyan
Therapeutic Drug Monitoring, 2007
View PDFchevron_right
The Challenges of Predicting Drug-Induced QTc Prolongation in Humans
Michael K Pugsley
Toxicological Sciences, 2022
View PDFchevron_right
Sensitivity and Reliability of Halothane-anaesthetized Microminipigs to Assess Risk of Drug-induced Long QT Syndrome
Atsushi Sugiyama
Basic & clinical pharmacology & toxicology, 2017
View PDFchevron_right
Pharmacokinetic-Pharmacodynamic Analysis of the Electrocardiographic Effects of Terfenadine and Quinidine in Rats
Meindert Danhof
Biological & Pharmaceutical Bulletin, 1996
View PDFchevron_right
Effects of halothane and sevoflurane on QT dispersion in paediatric patients
Hakan Canatay
Paediatric anaesthesia, 2003
View PDFchevron_right
Pharmacokinetics of Halothane in man: A novel approach
Й Й
1971
View PDFchevron_right
Comparative cardiac effects of antimalarial drug halofantrine with or without concomitant administration of kolanut or fluconazole in healthy volunteers
Kayode Adedapo
African Health Sciences
View PDFchevron_right
Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variability
James D.
American Heart Journal, 1996
View PDFchevron_right
Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole
Mei Khoo
Journal of Pharmaceutical Sciences, 1998
View PDFchevron_right
Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria
Sanjeev Krishna
British Journal of Clinical Pharmacology, 1993
View PDFchevron_right
Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices
Elaine Leite, George Machado-Coelho, Vanessa Carla Furtado Mosqueira
Life Sciences, 2007
View PDFchevron_right
Haloperidol affects coupling between QT and RR intervals in guinea pig isolated heart
Veronika Mrkvicová
Journal of Pharmacological Sciences, 2018
View PDFchevron_right
Problems of Heart Rate Correction in Assessment of Drug-Induced QT Interval Prolongation
Marek Malik
Journal of Cardiovascular Electrophysiology, 2001
View PDFchevron_right
A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine
Christopher Porter
Journal of Pharmaceutical Sciences, 1996
View PDFchevron_right
Development and Validation of Novel Hydrotropic Solubilization Method for Spectrophotometric Determination of Halofantrine in Pure and Solid Dosage form
Ngozi Nwodo
View PDFchevron_right
Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines
Karel Van Ammel
British Journal of Pharmacology, 2008
View PDFchevron_right